Until now, three key protein biomarkers have shown great help in guiding prognosis and therapy for BC, including progesterone receptor (PR), estrogen receptor (ER), and human epidermal growth factor (EGF) receptor 2 (HER2) (De la Mare et al., 2014). This evidence concerns the gene ESR1 and breast cancer.